SEC Company Response from IR BIOSCIENCES HOLDINGS INC (CIK 0000793043) — Feb 16, 2005
IR BIOSCIENCES HOLDINGS INC (CIK 0000793043)
Date: Feb. 16, 2005 · CIK: 0000793043 · Accession: 0001185185-05-000083
AI Filing Summary & Sentiment
Letter
February 16, 2005 Via Edgar and Facsimile (202) 942-9638 -------------------------------------- Division of Corporation Finance Securities and Exchange Commission 450 5th Street, N.W. Washington D.C. 20549 Attn: Lillian Brown
Re: IR Biosciences Holdings, Inc. Schedule TO-I (File No. 005-40624)
Dear Ms. Brown:
On behalf of IR Biosciences Holdings, Inc., a Delaware corporation (the "Company"), as transmitted pursuant to Rule 101(a) of Regulation S-T, the following is to document our understanding with respect to the status of the staff's comments with respect to the above-referenced filing.
Pursuant to our telephone discussion on Tuesday, February 15, 2004, we hereby confirm that any written notice of an extension of the Offer by the Company shall be received by the Warrant holders no later than 5:00 pm on the Expiration Date, in accordance with the requirements of Rule 14e-1 of the Securities Exchange Act of 1934, as amended. We further confirm that, in addition to delivery of notice materials to the Warrant holders, the Company will file any notice of an extension or amendment of the Offer in a Form 8-K pursuant to the public announcement requirement of Rule 14e-1.
We understand that the Commission has no further comments on the above-referenced filing.
If you have any questions or further comments, please do not hesitate to contact the undersigned or Michael Yu at (310) 552-5000 or via fax at (310) 552-5001.
Sincerely,
/s/ Katherine J. Blair
Show Raw Text
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.txt
<TEXT>
Katherine J. Blair
310.552.5017
Fax: 310.552.5001
kblair@klng.com
February 16, 2005
Via Edgar and Facsimile (202) 942-9638
--------------------------------------
Division of Corporation Finance
Securities and Exchange Commission
450 5th Street, N.W.
Washington D.C. 20549
Attn: Lillian Brown
Re: IR Biosciences Holdings, Inc.
Schedule TO-I (File No. 005-40624)
Dear Ms. Brown:
On behalf of IR Biosciences Holdings, Inc., a Delaware corporation (the
"Company"), as transmitted pursuant to Rule 101(a) of Regulation S-T, the
following is to document our understanding with respect to the status of the
staff's comments with respect to the above-referenced filing.
Pursuant to our telephone discussion on Tuesday, February 15, 2004, we hereby
confirm that any written notice of an extension of the Offer by the Company
shall be received by the Warrant holders no later than 5:00 pm on the Expiration
Date, in accordance with the requirements of Rule 14e-1 of the Securities
Exchange Act of 1934, as amended. We further confirm that, in addition to
delivery of notice materials to the Warrant holders, the Company will file any
notice of an extension or amendment of the Offer in a Form 8-K pursuant to the
public announcement requirement of Rule 14e-1.
We understand that the Commission has no further comments on the
above-referenced filing.
If you have any questions or further comments, please do not hesitate to contact
the undersigned or Michael Yu at (310) 552-5000 or via fax at (310) 552-5001.
Sincerely,
/s/ Katherine J. Blair
Katherine J. Blair
<PAGE>
Division of Corporation Finance
Securities and Exchange Commission
Attn: Lillian Brown
February 16, 2005
Page 2
cc: Michael K. Wilhelm
John N. Fermanis
Thomas J. Poletti
Michael S. Yu
- 2 -
</TEXT>
</DOCUMENT>